Clinical trials
Glucose Intolerance trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Guadalajara | 7 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 4 |
| Takeda | 2 |
| Coordinación de Investigación en Salud, Mexico | 1 |
| Daiichi Sankyo | 1 |
| Instituto Tecnologico y de Estudios Superiores de Monterey | 1 |
| Sanofi | 1 |
| Unidad de Investigacion Medica en Epidemiologia Clinica | 1 |
| Universidad de Guanajuato | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Intolerance | 19 |
| Hyperglycemia | 6 |
| Insulin Resistance | 6 |
| Prediabetic State | 6 |
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 2 |
| Hypercholesterolemia | 1 |
| Hyperinsulinism | 1 |
| Inflammation | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.